SCHMEES NORBERT
No ORCID on file
· 144 papers in corpus
· active 2006-2011
Frequent coauthors
- SCHWEDE WOLFGANG 108
- FUHRMANN ULRIKE 108
- MOELLER CARSTEN 108
- SCHMIDT ANJA 108
- BOTHE ULRICH 96
- HILLISCH ALEXANDER 48
- SOBEK LOTHAR 48
- DROESCHER PETER 48
- KAUFMANN GUENTER 48
- BLUME THORSTEN 36
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel 14, 17-bridged pyrazolo-estrien and triazolo- estrien- derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2011
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…
2010
The present invention is directed to novel pyrazolo-estrien and triazolo-estrien-derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by an estrogen recepto…